美国甲状腺协会指南对低中危甲状腺癌手术范围预测不足
该研究回顾了447例细胞学阳性或可疑恶性甲状腺癌患者,按2015年美国甲状腺协会(ATA)指南评估初始甲状腺切除范围。结果显示,细胞学阳性者中约60%、可疑恶性者中约30%因术后中危病理特征需补充甲状腺切除,说明指南术前风险分层不足。
要点
- 细胞学阳性患者中约60%按ATA指南行肺叶切除后需补充切除
- 可疑恶性患者中约30%因中危特征需补充甲状腺切除
- 现有术前工具对中危病变预测不足,需改进风险分层
核心结论
- 按2015年ATA指南考虑肺叶切除的患者中,细胞学阳性者约60%、可疑恶性者约30%会因中危病变需补充甲状腺切除。
- 新ATA策略的成本与风险影响显著,需更好的术前风险分层工具。
研究设计与样本
- 回顾性研究,纳入连续447例细胞学阳性或可疑恶性、按旧版ATA指南行初始全甲状腺切除±淋巴结清扫的患者。
- 细胞学阳性380例,可疑恶性67例。
主要发现
- 术后中危组织学特征在细胞学阳性者中占46%(175/380),可疑恶性者中占15%(18/67)。
- 多因素分析中与中危病变相关的术前因素包括年龄≥45岁、女性、较大肿瘤、细针穿刺细胞学阳性及BRAF V600E或RET/PTC阳性。
临床怎么用
- 对细胞学阳性或可疑恶性、拟按ATA指南行肺叶切除的患者,应告知补充甲状腺切除的可能性较高。
- 术前可结合年龄、性别、肿瘤大小、细胞学结果及BRAF V600E/RET/PTC状态评估中危风险。
局限性
- 为单中心回顾性研究,患者按旧版ATA指南行初始全甲状腺切除,非直接验证肺叶切除队列。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Recent guidelines from the American Thyroid Association recommend thyroid lobectomy for intrathyroidal differentiated thyroid cancers <4 cm. Our aim was to examine histology from patients with cytologic results that were positive or suspicious for malignancy to assess the extent of initial thyroidectomy based on criteria from the 2015 American Thyroid Association guidelines. METHODS: We studied consecutive patients who had either a positive or suspicious for malignancy cytologic diagnosis and under prior American Thyroid Association guidelines underwent initial total thyroidectomy ± lymphadenectomy. RESULTS: Among 447 patients, high-risk features necessitating total thyroidectomy were present in 19% (72/380) of positive and 15% (10/67) of suspicious for malignancy patients (P = .5). Intermediate-risk features on histology were identified postoperatively in 46% (175/380) with positive and 15% (18/67) with suspicious for malignancy fine-needle aspiration results. In multivariable analysis, preoperative factors associated with intermediate-risk disease included age ≥45 years, women, larger tumor size, positive fine-needle aspiration cytology, and BRAF V600E or RET/PTC positivity. CONCLUSION: When patients are considered for lobectomy under the 2015 American Thyroid Association guidelines, ~ 60% with positive and 30% with suspicious for malignancy cytology would need completion thyroidectomy based on intermediate-risk disease. The cost and risk implications of the new American Thyroid Association strategy were substantial and better tools are needed to improve preoperative risk stratification.
引用
- Dhir M, McCoy KL, Ohori NP, et al. Correct extent of thyroidectomy is poorly predicted preoperatively by the guidelines of the American Thyroid Association for low and intermediate risk thyroid cancers. Surgery. 2017. PMID: 29128185. doi:10.1016/j.surg.2017.04.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。